Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Manchee

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Letters in Applied Microbiology|March 7, 1998
Production and purification of recombinant protective antigen and protective efficacy against Bacillus anthracisJ Miller, B W McBride, R J Manchee, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1996
Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in miceP Russell, S M Eley, D L Bell, et al.
Infection and Immunity|May 1, 1986
Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunityP C Turnbull, M G Broster, J A Carman, et al.
Nature|May 19, 1983
Decontamination of Bacillus anthracis on Gruinard Island?R J Manchee, M G Broster, I S Anderson, et al.
Nature|April 15, 1982
Anthrax islandR J Manchee, M G Broster, R M Henstridge, et al.
Nature|November 19, 1981
Bacillus anthracis on Gruinard IslandR J Manchee, M G Broster, J Melling, et al.
The Journal of Applied Bacteriology|November 1, 1993
The development and assessment of DNA and oligonucleotide probes for the specific detection of Bacillus anthracisR A Hutson, C J Duggleby, J R Lowe, et al.
Vaccine|November 1, 1995
A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine modelP Russell, S M Eley, S E Hibbs, et al.
Israel Journal of Medical Sciences|July 1, 1981
Mycoplasmal adherence with particular reference to the pathogenicity of Mycoplasma pulmonisD Taylor-Robinson, P M Furr, H A Davies, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Letters in Applied Microbiology|March 7, 1998
Production and purification of recombinant protective antigen and protective efficacy against Bacillus anthracisJ Miller, B W McBride, R J Manchee, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1996
Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in miceP Russell, S M Eley, D L Bell, et al.
Infection and Immunity|May 1, 1986
Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunityP C Turnbull, M G Broster, J A Carman, et al.
Nature|May 19, 1983
Decontamination of Bacillus anthracis on Gruinard Island?R J Manchee, M G Broster, I S Anderson, et al.
Nature|April 15, 1982
Anthrax islandR J Manchee, M G Broster, R M Henstridge, et al.
Nature|November 19, 1981
Bacillus anthracis on Gruinard IslandR J Manchee, M G Broster, J Melling, et al.
The Journal of Applied Bacteriology|November 1, 1993
The development and assessment of DNA and oligonucleotide probes for the specific detection of Bacillus anthracisR A Hutson, C J Duggleby, J R Lowe, et al.
Vaccine|November 1, 1995
A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine modelP Russell, S M Eley, S E Hibbs, et al.
Israel Journal of Medical Sciences|July 1, 1981
Mycoplasmal adherence with particular reference to the pathogenicity of Mycoplasma pulmonisD Taylor-Robinson, P M Furr, H A Davies, et al.
Pageof 2